• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

    8/27/25 8:55:00 AM ET
    $ABT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $ABT alert in real time by email

    NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Ashley Mastronardi delivers the pre-market update on August 27th

    • Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon.
    • As the most heavily weighted company in the S&P 500 at more than 8%, Nvidia's results will likely be felt by investors throughout the rest of the week and provide insight into the level of demand for AI.
    • The major averages are coming off a day of fractional gains with investors shaking off President Trump's move to fire Fed Governor Lisa Cook ahead of the Fed's next policy meeting in Mid-September.

    Opening Bell

    Abbott (NYSE:ABT) and the Big Ten Conference are teaming up to address the worst blood shortage in a generation

    Closing Bell

    Van Eck celebrates the 70th anniversary of Van Eck and its first ETF listing

    Click here to download the NYSE TV App

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update--wall-street-braces-for-nvidias-earnings-302539974.html

    SOURCE New York Stock Exchange

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $ICE

    CompanyDatePrice TargetRatingAnalyst
    Intercontinental Exchange Inc.
    $ICE
    10/13/2025$210.00Outperform → Strong Buy
    Raymond James
    Abbott Laboratories
    $ABT
    10/10/2025$145.00Buy
    The Benchmark Company
    Abbott Laboratories
    $ABT
    7/18/2025$145.00Hold → Buy
    Jefferies
    Abbott Laboratories
    $ABT
    6/16/2025$143.00Market Perform
    Leerink Partners
    Intercontinental Exchange Inc.
    $ICE
    10/14/2024$185.00Strong Buy → Outperform
    Raymond James
    Abbott Laboratories
    $ABT
    10/8/2024$130.00Outperform
    Oppenheimer
    Intercontinental Exchange Inc.
    $ICE
    9/27/2024$200.00Outperform
    RBC Capital Mkts
    Intercontinental Exchange Inc.
    $ICE
    9/26/2024$182.00Buy
    TD Cowen
    More analyst ratings

    $ABT
    $ICE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    SEC Filings

    View All

    Abbott Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    1/22/26 7:35:32 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Laboratories filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    12/12/25 4:10:48 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Intercontinental Exchange Inc.

    144 - Intercontinental Exchange, Inc. (0001571949) (Subject)

    12/5/25 4:24:53 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intercontinental Exchange upgraded by Raymond James with a new price target

    Raymond James upgraded Intercontinental Exchange from Outperform to Strong Buy and set a new price target of $210.00

    10/13/25 8:40:25 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    The Benchmark Company initiated coverage on Abbott Labs with a new price target

    The Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00

    10/10/25 8:35:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Labs upgraded by Jefferies with a new price target

    Jefferies upgraded Abbott Labs from Hold to Buy and set a new price target of $145.00

    7/18/25 7:54:43 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Stratton John G

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/5/26 6:46:46 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Roman Michael F

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/5/26 6:26:09 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

    NEW YORK, Feb. 3, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 3rd Stocks are mixed as investors track a heavy week of corporate earnings — including reports from NYSE‑listed Pfizer, Eaton, Uber, and Eli Lilly — while labor data is disrupted by the postponement of Friday's January Jobs Report due to the partial government shutdown.With government data delayed, market attention is shifting to private‑sector indicators and corporate outlook

    2/3/26 8:55:00 AM ET
    $ICE
    $ORCL
    $TYL
    Investment Bankers/Brokers/Service
    Finance
    Computer Software: Prepackaged Software
    Technology

    ICE Clear Credit's Treasury Clearing Service Receives SEC Approval and is Now Operationally Live

    Brings industry-standard clearing model to Treasury markets Prepares for launch of repo clearing later this year Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that the U.S. Securities and Exchange Commission (SEC) has approved its application and rulebook for ICE Clear Credit to expand its current registered Covered Clearing Agency (CCA) designation to add U.S. Treasury clearing. ICE Clear Credit's U.S. Treasury clearing service is now fully operationally live, providing market participants with welcome competition and the first ever alternative venue for clearing U.S. Treasury securities. "Since we first announced plans

    2/3/26 8:30:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    ICE Announces Strongest Trading Month in Its History

    245.8 Million Derivative Contracts Traded During January 2026 Highest Monthly U.S. Equities Notional Traded in NYSE History Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that January marked the strongest month for trading activity in its history with a record 245.8 million contracts traded, including a record 199 million futures traded and a record 46.9 million options traded. In addition, January 2026 marked the highest notional in NYSE history, with a record daily average of $202.5 billion in notional value of U.S. equities traded. Across ICE's derivatives markets, January marked new records for average daily volumes

    2/3/26 8:00:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Leadership Updates

    Live Leadership Updates

    View All

    Nanhua Singapore Becomes Exchange and Clearing Member of ICE Futures Singapore and ICE Clear Singapore

    Intercontinental Exchange (NYSE:ICE), a leading global provider of technology and data, today announced that Nanhua Singapore Pte. Ltd. (Nanhua Singapore) has become a member of ICE Futures Singapore and ICE Clear Singapore. With these appointments, Nanhua Singapore can trade and clear its own business and clients' business. "We are pleased to join ICE in Singapore, as becoming a member allows Nanhua Singapore to strengthen our trading and global clearing capabilities, providing our clients with expanded opportunities in international markets," said Zheng Peiyuan, Chief Executive Officer, Nanhua Singapore. "This membership underscores our commitment to delivering reliable and efficient se

    12/21/25 8:00:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"

    Movie to feature cameos from youth who have overcome significant heart health challenges and are part of the Abbott HeartMates community as well as professional football player and HeartMates ambassador Damar Hamlin "The More the Merrier" is the first Hallmark movie ever to include cameos from real-life individuals who have overcome cardiovascular challengesCharacter in the movie was inspired by Abbott HeartMates member Zeke Mankins, who has established a friendship with Hamlin through Hamlin's ambassador role for the HeartMates communityMovie premieres on Hallmark Channel on Nov. 28, 2025, during Hallmark's Merry Thanksgiving Weekend during "Countdown to Christmas"ABBOTT PARK, Ill., Nov. 4,

    11/4/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lord Hill of Oareford Elected to Board of Directors of Intercontinental Exchange

    Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced that its Board of Directors has elected The Rt. Hon. the Lord Hill of Oareford CBE (Lord Hill) as a new director, effective September 18, 2025. Lord Hill, who currently serves on the Board of Directors of ICE Endex Markets, a subsidiary of ICE, is also expected to join the Board of Directors of ICE Futures Europe subject to regulatory approval. "On behalf of the Board, I am pleased to welcome our colleague, Lord Hill, to his expanded role at ICE," said Jeffrey C. Sprecher, Founder, Chair and CEO of Intercontinental Exchange. "Lord Hill brings tremendous depth and breadth of experi

    9/18/25 4:15:00 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $ABT
    $ICE
    Financials

    Live finance-specific insights

    View All

    Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

    Fourth-quarter GAAP diluted EPS of $1.01; adjusted diluted EPS of $1.50 reflects growth of 12 percentFull-year 2025 GAAP diluted EPS of $3.72; adjusted diluted EPS of $5.15 reflects growth of 10 percentAbbott projects full-year 2026 organic sales growth to be in the range of 6.5% to 7.5%Abbott projects full-year 2026 adjusted diluted EPS of $5.55 to $5.80, which reflects 10 percent growth at the midpointABBOTT PARK, Ill., Jan. 22, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2025. Fourth-quarter sales increased 4.4 percent on a reported basis, 3.0 percent on an organic basis, or 3.8 percent when excluding COVID-19 testing-re

    1/22/26 7:30:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The New York Stock Exchange Develops Tokenized Securities Platform

    Will facilitate 24x7 trading of U.S. listed equities and ETFs Will allow for fractional share trading Will offer immediate settlement via tokenized capital The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, today announced its development of a platform for trading and on-chain settlement of tokenized securities, for which it will seek regulatory approvals. NYSE's new digital platform will enable tokenized trading experiences, including 24/7 operations, instant settlement, orders sized in dollar amounts, and stablecoin-based funding. Its design combines the NYSE's cutting-edge Pillar matching engine w

    1/19/26 8:00:00 AM ET
    $BK
    $C
    $ICE
    Major Banks
    Finance
    Investment Bankers/Brokers/Service

    Abbott hosts conference call for fourth-quarter earnings

    ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day. About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medica

    1/5/26 4:30:00 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $ICE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/13/24 4:55:58 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Intercontinental Exchange Inc. (Amendment)

    SC 13G/A - Intercontinental Exchange, Inc. (0001571949) (Subject)

    2/13/24 1:23:13 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/23 10:54:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care